Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to RenovoRx, Inc.’s names, not what it holds today.
Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
1
Against none in 2024 and 1 in 2023
Applications published
15
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'11'14'16'17'18'19'20'21'22'23'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology2
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
RenovoRx, Inc. its own name
US, as the owner printed on each patent
8 publishedRenovoRx, Inc. its own name
named as the applicant on its applications, in US
7 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 6, 2025 | 12,290,564 | Methods and apparatuses for treating tumors | Pharmaceuticals | RenovoRx, Inc. |
| Jan 3, 2023 | 11,541,211 | Methods for delivery of therapeutic materials to treat cancer | Medical technology | RenovoRx, Inc. |
| Jul 6, 2021 | 11,052,224 | Methods for treating cancerous tumors | Medical technology | RenovoRx, Inc. |
| Jun 30, 2020 | 10,695,543 | Methods for treating cancerous tumors | Pharmaceuticals | RenovoRx, Inc. |
| Dec 24, 2019 | 10,512,761 | Methods for delivery of therapeutic materials to treat pancreatic cancer | Medical technology | RenovoRx, Inc. |
| Oct 16, 2018 | 10,099,040 | Occlusion catheter system and methods of use | Medical technology | RenovoRx, Inc. |
| Oct 11, 2016 | 9,463,304 | Devices, methods and kits for delivery of therapeutic materials to a pancreas | Medical technology | RenovoRx, Inc. |
| Oct 4, 2016 | 9,457,171 | Devices, methods and kits for delivery of therapeutic materials to a target artery | Medical technology | RenovoRx, Inc. |
| Sep 2, 2014 | 8,821,476 | Devices, methods and kits for delivery of therapeutic materials to a pancreas | Medical technology | RenovoRx, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 30, 2025 | 2025/0332253 | METHODS FOR TREATING TUMORS | Pharmaceuticals | RenovoRx, Inc. |
| Nov 9, 2023 | 2023/0355934 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | Medical technology | RenovoRx, Inc. |
| Sep 28, 2023 | 2023/0302262 | METHODS AND APPARATUSES FOR DELIVERY OF THERAPEUTIC MATERIALS FOR THE TREATMENT OF CANCER | Medical technology | RenovoRx, Inc. |
| Apr 14, 2022 | 2022/0111184 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | Medical technology | RenovoRx, Inc. · patent 11,541,211 granted from it |
| Nov 4, 2021 | 2021/0338977 | METHODS FOR TREATING CANCEROUS TUMORS | Medical technology | RenovoRx, Inc. |
| Sep 2, 2021 | 2021/0268107 | METHODS AND APPARATUSES FOR TREATING TUMORS | Pharmaceuticals | RenovoRx, Inc. · patent 12,290,564 granted from it |
| Jul 2, 2020 | 2020/0206481 | METHODS FOR DELIVERY OF THERAPEUTIC MATERIALS TO TREAT CANCER | Medical technology | RenovoRx, Inc. |
| Mar 12, 2020 | 2020/0078555 | METHODS FOR TREATING CANCEROUS TUMORS | Medical technology | RenovoRx, Inc. · patent 11,052,224 granted from it |
| Nov 22, 2018 | 2018/0333563 | METHODS FOR TREATING CANCEROUS TUMORS | Pharmaceuticals | RenovoRx, Inc. · patent 10,695,543 granted from it |
| Jun 8, 2017 | 2017/0157370 | OCCLUSION CATHETER SYSTEM AND METHODS OF USE | Medical technology | RenovoRx, Inc. · patent 10,099,040 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.